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Items for this week’s Epi Update include: 
• Review: FDA approved COVID-19 tests, including at-home and lab based options 
• COVID-19’s impact on healthcare-associated infection (HAI) rates 
• Infographic: Clinicians – Care for yourself one small way each day 
• Meeting announcements and training opportunities 
 
Review: FDA approved COVID-19 tests, including at-home and lab based options 
There are now many FDA EAU approved COVID 19 Tests: 235 molecular or PCR tests 
detecting RNA of the virus, and 11 antigen tests which detect surface proteins of the virus. 
 
There are: 
• 17 rapid point-of-care tests that are performed in a doctor’s office, pharmacy, etc.  
• 38 at-home tests that are sent to a laboratory for testing  
• 5 at-home tests that can be performed by anyone 
 
The following Antigen tests can be collected and performed at home: 
• BinaxNOW COVID-19 Self-Test  
• QuickVue At Home OTC COVID-19 Test 
• BD Veritor At Home COVID-19 Test  
• Ellume COVID-19 Home Test OTC 
• CareStart COVID-19 Antigen Home Test 
 
The following Antigen tests can be collected and performed at CLIA sites (high complexity, 
moderate complexity, or under a CLIA Certificate of Waiver): 
• InteliSwab COVID-19 Rapid Test Over the Counter 
• BinaxNOW COVID-19 (Prescription Home Testing) 
• BinaxNOW COVID-19 Ag Card 2 Home Test (Proctor Supervised) 
• BinaxNOW COVID-19 Ag 2 Card Home Test, Telehealth (Proctor Supervised) 
• InteliSwab COVID-19 Rapid Test Rx (Prescription Home Testing) 
• QuickVue At Home COVID-19 (Prescription Home Testing) 
 
For more information about FDA approved tests, visit www.fda.gov/consumers/consumer-
updates/coronavirus-disease-2019-testing-basics  
COVID-19’s impact on healthcare-associated infection (HAI) rates 
On September 3, CDC published a report summarizing the impact of the COVID-19 pandemic 
on rates of healthcare-associated infections (HAIs) in U.S. hospitals. Data reported to CDC’s 
National Healthcare Safety Network (NHSN) found a significant increase in the following HAIs:  
• central line-associated bloodstream infections (CLABSIs) 
• catheter-associated urinary tract infections (CAUTIs) 
• ventilator-associated events (VAEs) 
• methicillin-resistant Staphylococcus aureus (MRSA) bacteremia 
 
A similar trend was highlighted in a CDC MMWR published in December 2020. 
 
While the causes of such increases are not yet fully understood, it may be in relation to staffing 
challenges, changes in PPE practices, and other infection prevention and control factors. 
These increases further emphasize the importance of prioritizing continuity of core infection 
prevention and control practices (training for and auditing of hand hygiene, PPE use, 
environmental cleaning, etc.) to the greatest extent possible during COVID-19 surges and 
returning to normal operating procedures as soon as capacity allows. 
 
For more information about conventional infection prevention and control practices, 
visit www.cdc.gov/infectioncontrol/index.html.  
 
Infographic: Clinicians – Care for yourself one small way each day 
 
 
To view in full size, visit www.cdc.gov/coronavirus/2019-ncov/downloads/communication/print-
resources/Clinicians-Care-for-Yourself-card.pdf.  
 
Meeting announcements and training opportunities 
IDPH and SHL will be hosting the Iowa Influenza Surveillance Annual Webinar for the 2021-22 
Season on September 27 at 12:00 noon. The webinar will provide an overview of influenza 
surveillance and response including a summary of recent seasons, testing guidance, 
immunization recommendations, outbreak response, and antiviral treatment and prophylaxis. 
The intended audience includes healthcare providers, school staff, local public health, 
laboratorians and other public health professionals. To register, visit 
https://us02web.zoom.us/webinar/register/WN_dUTaw4gUT0iYfVhHBHzVJA.  
 
Have a healthy and happy week! 
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